Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Assets Average (2016 - 2025)

Historic Assets Average for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to $169.8 million.

  • OptimizeRx's Assets Average rose 44.69% to $169.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $169.8 million, marking a year-over-year increase of 44.69%. This contributed to the annual value of $177.3 million for FY2024, which is 1148.24% up from last year.
  • As of Q3 2025, OptimizeRx's Assets Average stood at $169.8 million, which was up 44.69% from $168.5 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Assets Average ranged from a high of $179.9 million in Q1 2024 and a low of $93.9 million during Q1 2021
  • Moreover, its 5-year median value for Assets Average was $141.7 million (2022), whereas its average is $146.8 million.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 13944.79% in 2021, then crashed by 1343.62% in 2023.
  • Over the past 5 years, OptimizeRx's Assets Average (Quarter) stood at $137.8 million in 2021, then decreased by 1.85% to $135.3 million in 2022, then grew by 13.6% to $153.7 million in 2023, then grew by 9.46% to $168.2 million in 2024, then grew by 0.96% to $169.8 million in 2025.
  • Its last three reported values are $169.8 million in Q3 2025, $168.5 million for Q2 2025, and $169.5 million during Q1 2025.